Completed
Topics
Opioid use disorder (OUD)—a chronic brain disease defined as a problematic pattern of opioid use (prescription opioids, fentanyl, heroin, or other illicit opioids) that leads to significant impairment or distress—imposes heavy costs on individuals, their families, and society. Methadone is one of three safe and highly effective FDA-approved medications to treat OUD; however, stringent laws and regulatory policies pose substantial barriers to provision of and access to treatment. This two-day public workshop will examine the current federal regulatory and legal landscape regarding provision of and access to methadone for the treatment of OUD.
Featured publication
Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop
Proceedings
·2022
Methadone is a Food and Drug Administration- (FDA-) approved medication for treating opioid use disorder (OUD), a chronic brain disease that affects more than 2.7 million people in the United States aged 12 and older. Despite its effectiveness in saving lives, many barriers impede access to, initiat...
View details